Gynecologic Oncology

Lymphangiogenesis and Lymph Node Microdissemination
pp. 1-3(3)
Authors: Van Trappen P.O.; Pepper M.S.

Abnormal Cervicovaginal Cytology in Women with Lupus: A Retrospective Cohort Study
pp. 4-6(3)
Authors: Dhar J.P.; Kmak D.; Bhan R.; Pishorodi L.; Ager J.; Sokol R.J.

Evaluation of Recombinant Human Interleukin-12 in Patients with Recurrent or Refractory Ovarian Cancer: A Gynecologic Oncology Group Study
pp. 7-10(4)
Authors: Hurteau J.A.; Blessing J.A.; DeCesare S.L.; Creasman W.T.

Prognostic Factors in Surgically Treated Stage Ib-IIb Cervical Carcinomas with Special Emphasis on the Importance of Tumor Volume
pp. 11-16(6)
Authors: Trattner M.; Graf A.-H.; Lax S.; Forstner R.; Dandachi N.; Haas J.; Pickel H.; Reich O.; Staudach A.; Winter R.

Positive Emission Tomography for Evaluating a Complete Clinical Response in Patients with Ovarian or Peritoneal Carcinoma: Correlation with Second-Look Laparotomy
pp. 17-21(5)
Authors: Rose P.G.; Faulhaber P.; Miraldi F.; Abdul-Karim F.W.

The Correlation between Colposcopically Directed Cervical Biopsy and Loop Electrosurgical Excision Procedure Pathology and the Effect of Time on That Agreement
pp. 22-26(5)
Authors: Barker B.; Garcia F.; Lozevski J.; Warner J.; Hatch K.

High Prevalence of Oncogenic Human Papillomavirus in the Genital Tract of Women with Human Immunodeficiency Virus
pp. 27-31(5)
Authors: Volkow P.; Rub S.; Lizano M.; Carrillo A.; Vilar-Compte D.; Garca-Carranca A.; Sotelo R.; Garca B.; Sierra-Madero J.; Mohar A.

Neuroendocrine Cervical Carcinoma: A Diagnostic and Therapeutic Challenge
pp. 32-39(8)
Authors: Bermudez A.; Vighi S.; Garca A.; Sardi J.

Three-Dimensional Power Doppler Ultrasound Improves the Diagnostic Accuracy for Ovarian Cancer Prediction
pp. 40-48(9)
Authors: Cohen L.S.; Escobar P.F.; Scharm C.; Glimco B.; Fishman D.A.

Interleukin-6 in Cervical Cancer: The Relationship with Vascular Endothelial Growth Factor
pp. 49-56(8)
Authors: Wei L.-H.; Kuo M.-L.; Chen C.-A.; Cheng W.-F.; Cheng S.-P.; Hsieh F.-J.; Hsieh C.-Y.

An Immunomagnetic-Based Method for the Purification of Ovarian Cancer Cells from Patient-Derived Ascites
pp. 57-63(7)
Authors: Barker S.D.; Casado E.; Gomez-Navarro J.; Xiang J.; Arafat W.; Mahasreshti P.; Pustilnik T.B.; Hemminki A.; Siegal G.P.; Alvarez R.D.; Curiel D.T.

Characteristics of Ovarian and Uterine Cancers in a Cohort of in Vitro Fertilization Patients
pp. 64-68(5)
Authors: Venn A.; Jones P.; Quinn M.; Healy D.

Allelotype of Papillary Serous Peritoneal Carcinomas
pp. 69-76(8)
Authors: Cass I.; Baldwin R.L.; Fasylova E.; Fields A.L.; Klinger H.P.; Runowicz C.D.; Karlan B.Y.

Synthetic Peptides Induce a Cytotoxic Response against Human Papillomavirus Type-18
pp. 77-83(7)
Authors: Castellanos M.R.; Hayes R.L.; Maiman M.A.

Uptake of a Cholesterol-Rich Emulsion by Neoplastic Ovarian Tissues
pp. 84-87(4)
Authors: Ades A.; Carvalho J.P.; Graziani S.R.; Amancio R.F.; Souen J.S.; Pinotti J.A.; Maranhao R.C.

Ten-Year Survival of Patients with Locally Advanced, Stage IB-IIB Cervical Cancer after Neoadjuvant Chemotherapy and Radical Hysterectomy
pp. 88-93(6)
Authors: Hwang Y.Y.; Moon H.; Cho S.H.; Kim K.T.; Moon Y.J.; Kim S.R.; Kim D.S.

Allele Loss on Chromosome 1p36 in Epithelial Ovarian Cancers
pp. 94-98(5)
Authors: Alvarez A.A.; Lambers A.R.; Lancaster J.M.; Maxwell G.L.; Ali S.; Gumbs C.; Berchuck A.; Futreal P.A.

Topoisomerase II Immunostaining as a Prognostic Marker for Survival in Ovarian Cancer
pp. 99-104(6)
Authors: Gotlieb W.H.; Goldberg I.; Weisz B.; Davidson B.; Novikov I.; Kopolovic J.; Ben-Baruch G.

Prognostic Factors of Krukenberg's Tumor
pp. 105-109(5)
Authors: Kim H.K.; Heo D.S.; Bang Y.-J.; Kim N.K.

Carboxyterminal Telopeptide of Type I Collagen (ICTP) in Predicting Prognosis in Epithelial Ovarian Cancer
pp. 110-115(6)
Authors: Simojoki M.; Santala M.; Risteli J.; Kauppila A.

Production of Steroids by Human Ovarian Surface Epithelial Cells in Culture: Possible Role of Progesterone as Growth Inhibitor
pp. 116-121(6)
Authors: Ivarsson K.; Sundfeldt K.; Brannstrom M.; Janson P.O.

The Effect of Nulliparity on Survival in Endometrial Cancer at Different Ages
pp. 122-126(5)
Authors: Hachisuga T.; Fukuda K.; Hirakawa T.; Kawarabayashi T.

Inhibitory Effects of 17-Estradiol and Progesterone on Ovarian Carcinoma Cell Proliferation: A Potential Role for Inducible Nitric Oxide Synthase
pp. 127-138(12)
Authors: Keith Bechtel M.; Bonavida B.

Evaluation of a Region on Chromosome 1p in Ovarian Serous Carcinoma That Is Frequently Deleted in Uterine Papillary Serous Carcinoma
pp. 139-142(4)
Authors: Herzog T.J.; Kowalski L.D.; Liu H.; Arlt M.; Swisher E.

The Clinical Significance of Occult Macroscopically Positive Retroperitoneal Nodes in Patients with Epithelial Ovarian Cancer
pp. 143-149(7)
Authors: Eisenkop S.M.; Spirtos N.M.

Sigmoid Perforation Following Radiation Therapy in Patients with Cervical Cancer
pp. 150-155(6)
Authors: Ramirez P.T.; Levenback C.; Burke T.W.; Eifel P.; Wolf J.K.; Gershenson D.M.

Treatment of Uterine Papillary Serous Carcinoma with Paclitaxel
pp. 156-161(6)
Authors: Ramondetta L.; Burke T.W.; Levenback C.; Bevers M.; Bodurka-Bevers D.; Gershenson D.M.

Vascular Endothelial Growth Factor C Gene Expression Is Closely Related to Invasion Phenotype in Gynecological Tumor Cells
pp. 162-166(5)
Authors: Ueda M.; Terai Y.; Kumagai K.; Ueki K.; Yamaguchi H.; Akise D.; Ueki M.

10-Gy Single-Fraction Pelvic Irradiation for Palliation and Life Prolongation in Patients with Cancer of the Cervix and Corpus Uteri
pp. 167-171(5)
Authors: Onsrud M.; Hagen B.; Strickert T.

Nitric Oxide-Dependent Apoptosis in Ovarian Carcinoma Cell Lines
pp. 172-176(5)
Authors: Rieder J.; Jahnke R.; Schloesser M.; Seibel M.; Czechowski M.; Marth C.; Hoffmann G.

Negative Predictive Value of Human Papillomavirus Test Following Conization of the Cervix Uteri
pp. 177-180(4)
Authors: Jain S.; Tseng C.-J.; Horng S.-G.; Soong Y.-K.; Pao C.C.

Primary Osteosarcoma of the Uterine Corpus: Report of a Case with Immunohistochemical and Ultrastructural Study
pp. 181-186(6)
Authors: Hardisson D.; Simon R.S.; Burgos E.

Large Cell Neuroendocrine Cervical Carcinoma: A Report of Two Cases and Review of the Literature
pp. 187-191(5)
Authors: Krivak T.C.; McBroom J.W.; Sundborg M.J.; Crothers B.; Parker M.F.

Fatal Recurrent Ureteroarterial Fistulas after Exenteration for Cervical Cancer
pp. 192-196(5)
Authors: DePasquale S.E.; Mylonas I.; Falkenberry S.S.

Bladder Carcinoma Associated with Cyclophosphamide Therapy for Ovarian Cancer Occurring with a Latency of 20 Years
pp. 197-199(3)
Authors: Volm T.; Pfaff P.; Gnann R.; Kreienberg R.

Transitional Cell Carcinoma of the Bladder Mimicking Recurrent Paget's Disease of the Vulva: Report of Two Cases, with One Occurring in a Myocutaneous Flap
pp. 200-204(5)
Authors: Boardman C.H.; Webb M.J.; Cheville J.C.; Lerner S.E.; Zincke H.

Is the Invasion Depth in Millimeters Valid to Determine the Prognosis of Early Invasive Cervical Adenocarcinoma?: A Case of Recurrent FIGO Stage IA1 Cervical Adenocarcinoma
pp. 205-207(3)
Authors: Utsugi K.; Shimizu Y.; Akiyama F.; Hasumi K.

Cutaneous Metastasis of Papillary Serous Uterine Cancer
pp. 208-211(4)
Authors: Elit L.; Lukka H.; Friedman E.

Metastatic Serous Borderline Ovarian Tumor in an Internal Mammary Lymph Node: A Case Report and Review of the Literature
pp. 212-215(4)
Authors: Chamberlin M.D.; Eltabbakh G.H.; Mount S.L.; Leavitt B.J.

Endometrial Carcinoma and an Unusual Presentation of Bone Metastasis: A Case Report
pp. 216-218(3)
Authors: Sahinler I.; Erkal H.; Akyazici E.; Atkovar G.; Okkan S.

Papers to Appear in Forthcoming Issues - Volume 81, Number 1 (2001), pages 333-334
pp. 219-219(1)
Authors: Yamamoto K.; Hoshiai H.; Noda K.

Papers to Appear in Forthcoming Issues
pp. 220-220(1)